IMMUCELL CORP /DE/ Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Immucell Corp /De/ quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Immucell Corp /De/ Return On Equity for the quarter ending September 30, 2024 was -15.3 %, a 32.3% increase year-over-year.
  • Immucell Corp /De/ annual Return On Equity for 2023 was -21.8 %, a 180% decline from 2022.
  • Immucell Corp /De/ annual Return On Equity for 2022 was -7.79 %, a 3014% decline from 2021.
  • Immucell Corp /De/ annual Return On Equity for 2021 was -0.25 %, a 93% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -21.8 -14 -180% Jan 1, 2023 Dec 31, 2023
2022 -7.79 -7.54 -3014% Jan 1, 2022 Dec 31, 2022
2021 -0.25 +3.35 +93% Jan 1, 2021 Dec 31, 2021
2020 -3.6 +0.79 +18% Jan 1, 2020 Dec 31, 2020
2019 -4.39 +5.85 +57.2% Jan 1, 2019 Dec 31, 2019
2018 -10.2 -9.45 -1196% Jan 1, 2018 Dec 31, 2018
2017 -0.79 -3.75 -127% Jan 1, 2017 Dec 31, 2017
2016 2.96 -9.01 -75.3% Jan 1, 2016 Dec 31, 2016
2015 12 +13.8 Jan 1, 2015 Dec 31, 2015
2014 -1.81 -3.06 -246% Jan 1, 2014 Dec 31, 2014
2013 1.24 +0.27 +27.8% Jan 1, 2013 Dec 31, 2013
2012 0.97 +5.48 Jan 1, 2012 Dec 31, 2012
2011 -4.51 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.